Dr. Niciu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 Hawkins Dr
Iowa City, IA 52242Phone+1 319-356-1549
Education & Training
Yale-New Haven Medical CenterResidency, Psychiatry, 2008 - 2012
Uconn School Of MedicineClass of 2008
Certifications & Licensure
IA State Medical License 2018 - 2025
CT State Medical License 2010 - 2018- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- University of Iowa Interventional Psychiatry Service Patient Registry Start of enrollment: 2020 Nov 02
- Ketamine Alcohol (in Treatment-Resistant Depression) Start of enrollment: 2014 Apr 23
Roles: Principal Investigator, Contact, Sponsor-Investigator
Publications & Presentations
PubMed
- 15 citationsThe antidepressant efficacy of subanesthetic-dose ketamine does not correlate with baseline subcortical volumes in a replication sample with major depressive disorderMark J. Niciu, Nicolas D. Iadarola, Dipavo Banerjee, David A. Luckenbaugh, Minkyung Park
Journal of Psychopharmacology. 2017-10-17 - 146 citationsNeural correlates of change in major depressive disorder anhedonia following open-label ketamineNíall Lally, Allison C. Nugent, David A. Luckenbaugh, Mark J. Niciu, Jonathan P. Roiser
Journal of Psychopharmacology. 2015-02-17 - 73 citationsA single infusion of ketamine improves depression scores in patients with anxious bipolar depression.Dawn F. Ionescu, David A. Luckenbaugh, Mark J. Niciu, Erica M. Richards, Carlos A. Zarate
Bipolar Disorders. 2015-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
